DRUG GUIDELINE

Infliximab - Intravenous Medication Guideline
SCOPE (Area): (Exclude: Paediatrics Seek Advice), Medical Day Unit
SCOPE (Staff): Clinical Staff
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice) and Areas other than MDU


Preamble

See Appendix 1 for this Medication Guideline.


Related Documents

CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0549 - High Risk Medications
CPG0254 - Guidelines For The Preparation, Administration And Waste Disposal Of Monoclonal Antibodies
SOP0001 - Principles Of Clinical Care


References

Appendix 1 - Infliximab - Intravenous Medication Guideline



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 14/05/2024
Review Responsibility: Senior Pharmacist- Medication Guidelines & Smart Pumps Date for Review: 14/05/2027
Infliximab - Intravenous Medication Guideline - DRG0045 - Version: 5 - (Generated On: 03-06-2025 05:54)